Pfizer/Pharmacia deal
This article was originally published in The Rose Sheet
Executive Summary
Pharmaceutical firm to acquire Rogaine hair regrowth business and other OTC treatment products such as the Nicorette smoking cessation brand as part of the company's Rx-driven acquisition of Pharmacia. With $732 mil. in revenue in 2001, Pharmacia's OTC business will be folded into Pfizers significantly larger consumer health operations, Pfizer Chairman and CEO Hank McKinnel said during a 1July 15 merger briefing. Pfizer Consumer Healthcare, with sales of $2.45 bil. in 2001, includes Listerine mouthwash and Benadryl allergy remedies. Pfizer planning to acquire Pharmacia in a $60 bil. stock-for-stock transaction...
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.